A Phase 2, Multicenter Study to Assess the Safety and Ef

Project: Research project

Project Details

Description

A Phase 2, Multicenter Study to Assess the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Treatment of Patients with Metastatic Melanoma
StatusActive
Effective start/end date5/1/175/30/22

Funding

  • IOVANCE BIOTHERAPEUTICS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.